Palisade Bio increases authorized shares to 450M common and 7M preferred

Palisade Bio amended its certificate of incorporation to expand authorized Common Stock from prior levels to 450 million shares and Preferred Stock to 7 million shares. The amendment provides greater flexibility for future financings and capital allocation strategies.